(b) PROHIBITED ACTS.—Section 301 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 331), as 
amended by section 8(a) of this Act, is amended by adding 
at the end the following: 
‘‘(kk) The sale of a prescription drug, or the owner-
ship or operation of an Internet pharmacy, in violation of 
section 503B. 
‘‘(ll) The representation by advertisement, sales pres-
entation, direct communication (including telephone, fac-
simile, or electronic mail), or otherwise by an Internet 
pharmacy, that a prescription drug may be obtained from 
the Internet pharmacy without a prescription, in violation 
of section 503B. 
‘‘(mm) The acceptance of an advertisement from an 
Internet pharmacy by the provider of an interactive com-
puter service, unless the provider has on file a copy of 
the license issued to the Internet pharmacy under section 
503B.’’. 
(c) INJUNCTIVE PROCEEDINGS; LINKS TO ILLEGAL 
INTERNET PHARMACIES.—Section 302 of the Federal 
Food, Drug, and Cosmetic Act (21 U.S.C. 332) is amend-
ed by adding at the end the following: 
‘‘(c)(1) In the case of a violation of section 503B re-
lating to an illegal Internet pharmacy, the district courts 
of the United States and the United States courts of the
territories shall have jurisdiction to order a provider of 
an interactive computer service to remove, or disable ac-
cess to, an Internet website violating that section that re-
sides on a computer server that the provider controls or 
operates. 
‘‘(2) Relief under paragraph (1)— 
‘‘(A) shall be available only after provision to 
the provider of notice and an opportunity to appear; 
‘‘(B) shall not impose any obligation on the 
provider to monitor its service or to affirmatively 
seek facts indicating activity violating section 503B; 
and 
‘‘(C) shall specify the provider to which the re-
lief applies.’’. 
(d) IMPORTATION; RETURN
TO SENDER.—Section 
801 of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 381), as amended by section 7(b) of this Act, is 
amended by adding at the end the following: 
‘‘(q) UNLICENSED INTERNET PHARMACY.—If an 
Internet pharmacy is not licensed by the Secretary in ac-
cordance with section 503B, any shipment of a prescrip-
tion drug from such an Internet pharmacy to an individual 
shall be refused admission into the United States and the 
Secretary shall return the prescription drug, other than 
a prescription drug that is required to be destroyed, to
the Internet pharmacy at the expense of the Internet phar-
macy. 
‘‘(r) LICENSED INTERNET PHARMACY.—If a ship-
ment of a prescription drug from an Internet pharmacy 
licensed by the Secretary in accordance with section 503B 
to an individual is refused admission into the United 
States, the Secretary shall— 
‘‘(1) return the prescription drug, other than a 
prescription drug that is required to be destroyed, to 
the Internet pharmacy at the expense of the Internet 
pharmacy; and 
‘‘(2) provide the individual and the Internet 
pharmacy with a written notice that informs the in-
dividual and the Internet pharmacy of the refusal 
and of the reason for the refusal.’’. 
(e) REGULATIONS.—With respect to section 503B of 
the Federal Food, Drug, and Cosmetic Act (as added by 
subsection (a) of this section): 
(1) Not later than one year after the date of 
the enactment of this Act, the Secretary of Health 
and Human Services shall promulgate interim final 
regulations that are consistent with the Verified 
Internet Pharmacy Sites certification program devel-
oped by the National Association of Boards of Phar-
macy to carry out the amendments made by this sec-
tion. 
(2) The requirement of licensure under such 
section 503B takes effect on the date determined by 
the Secretary of Health and Human Services, but in 
no event later than 90 days after the effective date 
of the interim final regulations under paragraph (1). 
(3) Section 801(q) of such Act (as added by 
subsection (d) of this section) takes effect on the ef-
fective date that applies under paragraph (2) of this 
subsection. 
(4) For purposes of section 813 of such Act (as 
added by section 4 of this Act), an Internet phar-
macy located in Canada is deemed to be licensed 
under such section 503B pending the effective date 
that applies under paragraph (2) of this subsection. 
SEC. 10. CHAIN OF CUSTODY OF PRESCRIPTION DRUGS; 
NETWORK FOR NOTIFICATIONS REGARDING 
COUNTERFEIT DRUGS. 
(a) ELECTRONIC TRACK AND TRACE TECHNOLOGY; 
NETWORK FOR NOTIFICATIONS REGARDING COUNTER-
FEIT DRUGS.— 
(1) ELECTRONIC
TRACK
AND
TRACE
TECH-
NOLOGY.—Not later than December 31, 2007, the 
Secretary of Health and Human Services shall re-